214 related articles for article (PubMed ID: 36175317)
1. Free-indocyanine green-guided pelvic lymph node dissection during radical prostatectomy.
Claps F; de Pablos-Rodríguez P; Gómez-Ferrer Á; Mascarós JM; Marenco J; Collado Serra A; Casanova Ramón-Borja J; Calatrava Fons A; Trombetta C; Rubio-Briones J; Ramírez-Backhaus M
Urol Oncol; 2022 Nov; 40(11):489.e19-489.e26. PubMed ID: 36175317
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial.
Harke NN; Godes M; Wagner C; Addali M; Fangmeyer B; Urbanova K; Hadaschik B; Witt JH
World J Urol; 2018 Nov; 36(11):1817-1823. PubMed ID: 29767326
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical Prostatectomy.
Ramírez-Backhaus M; Mira Moreno A; Gómez Ferrer A; Calatrava Fons A; Casanova J; Solsona Narbón E; Ortiz Rodríguez IM; Rubio Briones J
J Urol; 2016 Nov; 196(5):1429-1435. PubMed ID: 27235788
[TBL] [Abstract][Full Text] [Related]
4. Personalised indocyanine-guided lymphadenectomy for prostate cancer: a randomised clinical trial.
de Pablos-Rodríguez P; Claps F; Rebez G; Vidal Crespo N; Gómez-Ferrer Á; Mascarós JM; Collado Serra A; Caltrava Fons A; Rubio-Briones J; Casanova Ramon Borja J; Ramírez Backhaus M
BJU Int; 2023 Nov; 132(5):591-599. PubMed ID: 37410659
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: the initial clinical experience in 50 patients.
Manny TB; Patel M; Hemal AK
Eur Urol; 2014 Jun; 65(6):1162-8. PubMed ID: 24289911
[TBL] [Abstract][Full Text] [Related]
6. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
7. A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
Wit EMK; KleinJan GH; Berrens AC; van Vliet R; van Leeuwen PJ; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2861-2871. PubMed ID: 37036490
[TBL] [Abstract][Full Text] [Related]
8. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
9. Lymph Node Fluorescence During Robot-Assisted Radical Prostatectomy With Indocyanine Green: Prospective Dosing Analysis.
Chennamsetty A; Zhumkhawala A; Tobis SB; Ruel N; Lau CS; Yamzon J; Wilson TG; Yuh BE
Clin Genitourin Cancer; 2017 Aug; 15(4):e529-e534. PubMed ID: 27939590
[TBL] [Abstract][Full Text] [Related]
10. A Specific Mapping Study Using Fluorescence Sentinel Lymph Node Detection in Patients with Intermediate- and High-risk Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection.
Nguyen DP; Huber PM; Metzger TA; Genitsch V; Schudel HH; Thalmann GN
Eur Urol; 2016 Nov; 70(5):734-737. PubMed ID: 26856960
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence-guided extended pelvic lymphadenectomy during robotic radical prostatectomy.
Özkan A; Köseoğlu E; Canda AE; Çil BE; Aykanat İC; Sarıkaya AF; Tarım K; Armutlu A; Kulaç İ; Barçın E; Falay FO; Kordan Y; Baydar DE; Balbay MD; Esen T
J Robot Surg; 2023 Jun; 17(3):885-890. PubMed ID: 36329287
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.
Liss MA; Palazzi K; Stroup SP; Jabaji R; Raheem OA; Kane CJ
World J Urol; 2013 Jun; 31(3):481-8. PubMed ID: 23512231
[TBL] [Abstract][Full Text] [Related]
13. Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis.
Wettstein MS; David LA; Pazhepurackel C; Qureshi AA; Zisman A; Nesbitt M; Saba K; Herrera-Caceres JO; Fankhauser CD; Ahmad A; Hamilton RJ; Eberli D; Zlotta AR; Sulser T; Fleshner NE; Poyet C; Finelli A; Hermanns T; Kulkarni GS
Prostate; 2021 Apr; 81(5):286-294. PubMed ID: 33599318
[TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
[TBL] [Abstract][Full Text] [Related]
15. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
[TBL] [Abstract][Full Text] [Related]
16. Impact of indocyanine green-guided extended pelvic lymph node dissection during robot-assisted radical prostatectomy.
Shimbo M; Endo F; Matsushita K; Hattori K
Int J Urol; 2020 Oct; 27(10):845-850. PubMed ID: 32634854
[TBL] [Abstract][Full Text] [Related]
17. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging.
Jeschke S; Lusuardi L; Myatt A; Hruby S; Pirich C; Janetschek G
Urology; 2012 Nov; 80(5):1080-6. PubMed ID: 22990053
[TBL] [Abstract][Full Text] [Related]
18. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
Heidenreich A; Ohlmann CH; Polyakov S
Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
[TBL] [Abstract][Full Text] [Related]
19. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
20. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
